Major milestone today in pragmatic clinical trials March 10, 2016NewsPatty McAdamsGoogle+LinkedinTwitter Congratulations to the REACHnet team for receiving the first IRB approval for the ADAPTABLE Aspirin Study. Post navigation ← ADAPTABLE provides a new approach to consent form development Adapting Good Clinical Practice Guidelines to Pragmatic Clinical Trials →